Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6) |
| |
| Authors: | G Tosato K B Seamon N D Goldman P B Sehgal L T May G C Washington K D Jones S E Pike |
| |
| Institution: | Division of Biochemistry and Biophysics, Food and Drug Administration, Bethesda, MD 20892. |
| |
| Abstract: | Soluble products of either Epstein-Barr virus (EBV)-infected B cells or activated monocytes promote the proliferation of EBV-infected B cells and permit their growth at low cell densities. This suggests that growth factors are important for B-cell immortalization by EBV. In this study, a monocyte-derived factor that promotes the growth of EBV-infected b cells was purified and identified as interferon-beta 2 (IFN-beta 2), which is also known as 26-kilodalton protein, B-cell differentiation factor (BSF-2), and interleukin-6 (IL-6). The purified protein has a specific activity of approximately 4 X 10(7) units per milligram of protein in assays of B-cell growth. Thus, IFN-beta 2/BSF-2 is a B-cell growth factor that promotes the proliferation of human B cells infected with EBV. |
| |
| Keywords: | |
|
|
